Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership
Millions of children receive anesthetic and sedation drugs each year for surgical and non-surgical procedures.
Over the past two decades, an expanding body of data from animal studies have demonstrated that exposure of the developing brain to anesthetic and sedation agents is associated with neurodegeneration
and long-term, likely permanent, deficits in cognitive function and behavior.
Under the Critical Path Initiative, SmartTots Public-Private Partnership (PPP) was established to address the critical public health issues associated with the safe use of anesthetic agents and sedatives in young children.
The objective of this cooperative agreement is to continue bridging the knowledge gaps, elucidating the risks related to the use of anesthetic and sedative agents in children, and developing strategies for optimizing brain health in children who require anesthesia and sedation care.
Over the past two decades, an expanding body of data from animal studies have demonstrated that exposure of the developing brain to anesthetic and sedation agents is associated with neurodegeneration
and long-term, likely permanent, deficits in cognitive function and behavior.
Under the Critical Path Initiative, SmartTots Public-Private Partnership (PPP) was established to address the critical public health issues associated with the safe use of anesthetic agents and sedatives in young children.
The objective of this cooperative agreement is to continue bridging the knowledge gaps, elucidating the risks related to the use of anesthetic and sedative agents in children, and developing strategies for optimizing brain health in children who require anesthesia and sedation care.
Agency: Department of Health and Human Services
Office: Food and Drug Administration
Estimated Funding: $2,750,000
Office: Food and Drug Administration
Estimated Funding: $2,750,000
Who's Eligible
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-057.html
Additional Information of Eligibility:
N/A
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-057.html
Contact:
Agency Email Description:
shashi.malhotra@fda.hhs.gov
Agency Email:
Date Posted:
2021-05-25
Application Due Date:
Archive Date:
2021-05-26
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Learn How to Identify and Avoid Grant Scams
